Adaptimmune Therapeutics PLC - - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ADAP Nasdaq 8731 http://www.adaptimmune.com/ 7.15 Stock Up +0.05

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adaptimmune Therapeutics PLC -

Abbvie Inks Immuno-Oncology Deal with Harpoon Therapeutics - Oct 20th, 2017 3:36 pm
Impax Laboratories and Amneal Pharmaceuticals Agree to Merge - Oct 18th, 2017 8:17 am
Immune Design's Sarcoma Candidate to Enter Phase III in 2018 - Oct 17th, 2017 8:04 am
The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene - Oct 17th, 2017 6:57 am
Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada - Oct 16th, 2017 4:07 pm
Bayer to Sell Select Business Lines to Close Monsanto Buyout - Oct 16th, 2017 3:43 pm
Shire's New Formulation of Oncaspar Gets CHMP Recommendation - Oct 16th, 2017 8:02 am
AcelRx's Opioid Painkiller Dsuvia Gets CRL, Shares Plunge - Oct 13th, 2017 9:05 am
Flexion's Zilretta Gets FDA Approval for Knee Pain, Stock Up - Oct 9th, 2017 8:15 am
James Noble, Adaptimmune CEO, to Participate in Upcoming Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology - Sep 22nd, 2017 8:00 am
Surging Earnings Estimates Signal Good News for Adaptimmune Therapeutics (ADAP) - Sep 21st, 2017 6:35 am
Zacks.com featured highlights: Adaptimmune Therapeutics, Barnes Group, Mobile TeleSystems, JA Solar Holdings and Newtek Business Services - Sep 13th, 2017 8:33 am
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO - Sep 7th, 2017 5:30 am
Adaptimmune Therapeutics Plc :ADAP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017 - Sep 6th, 2017 6:20 am
Adaptimmune to Present at Upcoming CAR-TCR Summit; CEO James Noble to be a Keynote Speaker - Aug 30th, 2017 6:00 am
Strength Seen in Adaptimmune Therapeutics (ADAP): Stock Soars 15.2% - Aug 29th, 2017 6:52 am
Adaptimmune Reports Second Quarter 2017 Financial Results - Aug 3rd, 2017 5:30 am
Adaptimmune to Report Second Quarter 2017 Financial Results on August 3, 2017 - Jul 31st, 2017 2:00 pm
Adaptimmune Therapeutics Plc :ADAP-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 - Jun 2nd, 2017 8:06 am